Cytek Biosciences

Historical price data

Cytek Biosciences is a mission-driven company advancing cell analysis through its innovative Full Spectrum Flow Cytometry (FSP) technology, which enables high-parameter, high-resolution cell profiling. The company has achieved significant growth, marked by public listing, strategic acquisitions, and recent recognition as a growth leader by TIME Magazine. Its strategy centers on a hybrid revenue model from instrument sales and high-margin recurring consumables, while expanding from research into clinical diagnostics and cell therapy manufacturing.

Proprietary Full Spectrum Flow Cytometry (FSP) technology that captures the entire emission spectrum of fluorochromes, enabling high-parameter (40+ color) single-cell analysis with superior resolution and flexible panel design compared to conventional filter-based cytometry.

Operates in a niche dominated by giants but maintains leadership in high-parameter spectral cytometry through superior technology flexibility and a focused platform. Competes directly with BD's FACSymphony, Beckman's CytoFLEX, and Sony's ID7000.